Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (44)

2020

  1. Ankyrin repeat and kinase domain containing 1 gene, and addiction vulnerability

    International Journal of Molecular Sciences, Vol. 21, Núm. 7

  2. Hypothalamic-pituitary axis response to a 0.25-MG dexamethasone test in women with fibromyalgia

    Stress, Vol. 23, Núm. 3, pp. 284-289

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

2018

  1. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807

2012

  1. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis

    Comprehensive Psychiatry, Vol. 53, Núm. 8, pp. 1063-1070

2009

  1. The ANKK1 kinase gene and psychiatric disorders

    Neurotoxicity Research, Vol. 16, Núm. 1, pp. 50-59

2008

  1. Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 1, pp. 257-266

  2. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)

    Genes, Brain and Behavior, Vol. 7, Núm. 7, pp. 796-801

  3. Patología dual en pacientes psiquiátricos hospitalizados: Prevalencia y características generales

    Investigacion Clinica, Vol. 49, Núm. 2, pp. 195-205

  4. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: Influence of dual diagnosis

    Psychopathology, Vol. 41, Núm. 1, pp. 58-64

  5. The role of behavioral impulsivity in the development of alcohol dependence: A 4-year follow-up study

    Alcoholism: Clinical and Experimental Research, Vol. 32, Núm. 9, pp. 1681-1687

2007

  1. Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3′ region of the DRD2 gene

    Neurotoxicity Research, Vol. 11, Núm. 1, pp. 51-59

  2. Changes in cortical volume with olanzapine in chronic schizophrenia

    Pharmacopsychiatry, Vol. 40, Núm. 4, pp. 135-139

  3. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder

    European Psychiatry, Vol. 22, Núm. 8, pp. 505-512

  4. Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders

    Actas Espanolas de Psiquiatria, Vol. 35, Núm. 2, pp. 122-129

  5. From dopaminergic genes to psychiatric disorders

    Neurotoxicity Research, Vol. 11, Núm. 1, pp. 61-71

2006

  1. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients

    Acta Psychiatrica Scandinavica, Vol. 114, Núm. 6, pp. 435-438

  2. Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, Núm. 2, pp. 106-111

  3. Impulsivity and sustained attention in pathological gamblers: Influence of childhood ADHD history

    Journal of Gambling Studies, Vol. 22, Núm. 4, pp. 451-461

  4. Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers

    American Journal of Psychiatry, Vol. 163, Núm. 3, pp. 488-493